Management of cytomegalovirus infection in solid organ transplantation.
about
Cytomegalovirus-induced immunopathology and its clinical consequencesPre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipientsCMV: Prevention, Diagnosis and TherapyCurrent and potential treatments for ubiquitous but neglected herpesvirus infectionsAntigenic Characterization of the HCMV gH/gL/gO and Pentamer Cell Entry Complexes Reveals Binding Sites for Potently Neutralizing Human AntibodiesSeropositivity of cytomegalovirus in patients with recurrent pregnancy loss.Detection of cytomegalovirus drug resistance mutations by next-generation sequencing.Use of leflunomide in renal transplant recipients with ganciclovir-resistant/refractory cytomegalovirus infection: a case series from the University of Chicago.Multicenter comparison of laboratory performance in cytomegalovirus and Epstein-Barr virus viral load testing using international standards.Human cytomegalovirus-specific T-cell immune reconstitution in preemptively treated heart transplant recipients identifies subjects at critical risk for infectionSingle Chain Antibodies Against gp55 of Human Cytomegalovirus (HCMV) for Prophylaxis and Treatment of HCMV Infections.Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody.Primary Cytomegalovirus Infection in Seronegative Kidney Transplant Patients Is Associated with Protracted Cold Ischemic Time of Seropositive Donor OrgansValidation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patientsValidation of cytomegalovirus immune competence assays for the characterization of CD8(+) T cell responses posttransplantThe human cytomegalovirus UL51 protein is essential for viral genome cleavage-packaging and interacts with the terminase subunits pUL56 and pUL89.Leukocyte Immunoglobulin-Like Receptor 1-Expressing Human Natural Killer Cell Subsets Differentially Recognize Isolates of Human Cytomegalovirus through the Viral Major Histocompatibility Complex Class I Homolog UL18.Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine.Update on cytomegalovirus infections of the gastrointestinal system in solid organ transplant recipients.Advances in cytomegalovirus-preventive strategies in solid organ transplantation: defending pre-emptive therapy.Human cytomegalovirus infection and atherothrombosis.Renal transplantation in human immunodeficiency virus (HIV)-positive children.The efficacy and cost-effectiveness of valacyclovir in cytomegalovirus prevention in solid organ transplantation.Clinical pharmacokinetics and pharmacodynamics of ganciclovir and valganciclovir in children with cytomegalovirus infection.Personalised dosing of medicines for children.Case report: Brincidofovir-induced reversible severe acute kidney injury in 2 solid-organ transplant for treatment of cytomegalovirus infectionPerformance of the MagNA Pure 96 system for cytomegalovirus nucleic acid amplification testing in clinical samples.Early cytomegalovirus-specific T-cell response and estimated glomerular filtration rate identify patients at high risk of infection after renal transplantation.Timing of CMV-specific effector memory T cells predicts viral replication and survival after allogeneic hematopoietic stem cell transplantation.Survey of CMV management in pediatric allogeneic HSCT programs, on behalf of the inborn errors, infectious diseases and pediatric diseases working parties of EBMT.Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study.Measuring T-cell responses against LCV and CMV in cynomolgus macaques using ELISPOT: potential application to non-clinical testing of immunomodulatory therapeutics.Human cytomegalovirus vaccine development: Immune responses to look into vaccine strategy.Precision Transplant Medicine: Biomarkers to the Rescue.Clinical significance of quantitative cytomegalovirus detection in bronchoalveolar lavage fluid in lung transplant recipients.
P2860
Q21195897-5FA5D661-62DE-4916-98B7-69B1B93F71F2Q24200991-3E9678DA-E9A0-4C7E-9419-0CCACF897959Q26824869-363C7240-2608-4C82-AF29-2959550D94F6Q27023452-2BB8FE92-A419-4020-AF44-842CBD9AFDBDQ28550400-4A8618FA-83F4-4FA2-BBF8-BA82C20560DCQ33833216-14E4D997-8B3D-45D7-A7D7-AE351ED36655Q34975934-786C1163-D57A-4402-8E6E-1B6D168A6992Q35592509-D3F3E01E-0F13-4FF5-932D-380564550D17Q35785478-3980E5C2-CB5E-47FF-8EB0-B4A331CFA7DEQ36023008-0F705120-963E-4F64-BF99-D3742D0E79B9Q36027654-25E844A7-F3B4-481C-8E11-4DB1F74C1214Q36084954-369CDCBF-8158-4505-ABE0-4FB8338DACC3Q36262672-E96F1CEF-9390-48CE-8B68-D58F3C25D6A1Q36299933-188F794B-6A6A-4D8D-8099-4AACDF6BF3CAQ36490685-B422A7D2-0A3A-4913-B37A-DF9966C8A118Q36559969-9B25A42A-2E59-4206-AE6C-51FE67D9CD5DQ36736566-1BF672A8-D992-4BC1-B617-39EB20A33550Q37409489-030FF54A-59CB-41CE-A05C-2438639993E3Q37962447-D0D240BC-7148-41FD-9715-CC89E2F8C3DDQ37965695-AF212F4B-368B-4375-BE4D-7C624400A683Q37967568-93198360-7931-469A-A0AC-8E5964A61E6CQ38201325-A252C6EE-AC5E-41DE-819A-B78B8F23182FQ38254037-F3A62765-86E6-4FAB-B7B5-D518BE57DC3DQ38271850-84B2A0D2-D73E-45E2-B325-F585A60F9B15Q38749764-F69D9B5E-AD21-4A01-A175-E51AC8110C3DQ40446799-461E3AB1-173B-4005-BC25-2BA047410CBBQ40520934-BF5AC5FC-729F-4F6E-A43C-9EABBA567E8AQ40791125-8BCE1B83-F778-4050-B840-BF212CA3C3CDQ42203312-40FC721C-AEF3-436C-B0DA-F24F63831DC3Q42242868-731E92CA-9FA9-4A4D-93FD-D353884E4A8AQ42259440-BA95B4B3-7F70-4E49-9747-008830AF0D34Q45905220-95F6F41C-A3C8-4EF9-85BD-073AFC1A5432Q47605886-25107EAD-6478-4943-B77D-D555B448EAE7Q47656083-0727E115-8A22-4EDE-B833-09523015E78BQ54289718-413D244C-5C13-4C71-867F-88C4260E1001
P2860
Management of cytomegalovirus infection in solid organ transplantation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Management of cytomegalovirus infection in solid organ transplantation.
@en
Management of cytomegalovirus infection in solid organ transplantation.
@nl
type
label
Management of cytomegalovirus infection in solid organ transplantation.
@en
Management of cytomegalovirus infection in solid organ transplantation.
@nl
prefLabel
Management of cytomegalovirus infection in solid organ transplantation.
@en
Management of cytomegalovirus infection in solid organ transplantation.
@nl
P2860
P356
P1476
Management of cytomegalovirus infection in solid organ transplantation.
@en
P2860
P2888
P304
P356
10.1038/NRNEPH.2010.141
P407
P577
2010-10-26T00:00:00Z